| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Arthur David J. serves as a Chief Executive Officer at DCOY. Across recent SEC filings that breaks down to 11 buys and 0 sells. Those positions are worth an estimated $189K at current prices.
Historically, Arthur David J.'s trades have earned a below-average insider score of 19/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -72.8%.
The biggest single holding is DCOY (~$189K) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 191,563 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | DCOY Salarius Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 43,900 | $0.18 | $7,984.60 | +3.2% | +15.7% | -66.9% | |
| Mar 3, 2022 | DCOY Salarius Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 139,488 | $0.39 | $54,539.81 | +126.6% | -54.7% | -77.8% | |
| Aug 17, 2021 | DCOY Salarius Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 4,000 | $0.90 | $3,582.00 | +2.0% | -13.4% | -73.7% | |
| Aug 19, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,000 | $1.01 | $2,020.00 | +200.0% | - | - | |
| Feb 11, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,175 | $1.15 | $2,501.25 | +2.7% | - | - |